title: Gonadal steroids and bone metabolism in young castrated male rats.
abstract: At 45 days of age, 40 male Wistar rats were castrated, then randomly divided into four groups, S.C. injected for 60 days after surgery either with 17beta-estradiol (E) 10 microg/kg BW/48 hours, progesterone (P) 140 microg/kg BW/48 hours, dihydrotestosterone (D) 2 microg/kg BW/48 hours, E + P + D same doses, or solvent alone (CX). Ten other rats were sham-operated (SH) and used as controls. Animals were put in balance to determine Ca and phosphorus (Pi) intestinal apparent absorption (IA Ca, IA Pi) and urinary pyridinium crosslinks excretion. Plasma was collected for measurement of intact-parathyroid hormone (PTH), calcitonin (CT), insulin-like growth factor I (IGF-I), 1,25 dihydroxyvitamin D (1,25(OH)(2)D), Ca, and Pi. Orchidectomy induced marked seminal vesicles atrophy and increased plasma CT, PTH, and Ca concentrations. IA Ca was significantly higher in P rats, however, neither castration nor any other treatment had significant effects. Orchidectomy decreased femoral length, dry weight, and Ca content, whereas E or D given alone or together with P improved endochondral growth and enhanced femoral Ca content. Again, bone mineral density was lowered by orchidectomy and reestablished by both E and EPD, even above SH values, this effect being more important at the metaphyseal levels. Urinary pyridinium cross-links excretion and plasma osteocalcin concentrations were higher in the CX animals than in the controls. Although E and D given alone did reduce both biochemical turnover markers, they showed additive effect when given together (EPD). In conclusion, in the young castrated male rat, E was more efficient than D for preventing bone loss, the most important effect being induced by a combination of E+P+D.
authors.affiliation: INRA Clermont-Theix, F-63122 St Genès-Champanelle, France.
authors.forename: N
authors.initials: N
authors.lastname: Gaumet-Meunier
authors.forename: V
authors.initials: V
authors.lastname: Coxam
authors.forename: S
authors.initials: S
authors.lastname: Robins
authors.forename: P
authors.initials: P
authors.lastname: Pastoureau
authors.forename: A
authors.initials: A
authors.lastname: Pointillart
authors.forename: M J
authors.initials: MJ
authors.lastname: Davicco
authors.forename: P
authors.initials: P
authors.lastname: Lebecque
authors.forename: J P
authors.initials: JP
authors.lastname: Barlet
mesh_terms: D000596:Amino Acids / Q000652:urine; D000818:Animals; D015415:Biomarkers / Q000652:urine; D001835:Body Weight; D015519:Bone Density; D001862:Bone Resorption / Q000097:blood / Q000517:prevention & control* / Q000652:urine; D002116:Calcitonin / Q000097:blood; D002118:Calcium / Q000097:blood; D013196:Dihydrotestosterone / Q000494:pharmacology*; D004338:Drug Combinations; D004958:Estradiol / Q000494:pharmacology*; D005269:Femur / Q000187:drug effects; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008297:Male; D009919:Orchiectomy; D015675:Osteocalcin / Q000097:blood; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D011374:Progesterone / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013977:Tibia / Q000187:drug effects; D014807:Vitamin D / Q000097:blood
chemical_list: D000596:Amino Acids; D015415:Biomarkers; D004338:Drug Combinations; D010281:Parathyroid Hormone; D013196:Dihydrotestosterone; D015675:Osteocalcin; D014807:Vitamin D; D010758:Phosphorus; D011374:Progesterone; D004958:Estradiol; D007334:Insulin-Like Growth Factor I; C036020:deoxypyridinoline; D002116:Calcitonin; D002118:Calcium